New Delhi: The delayed approval to Bharat Biotech’s Covid-19 vaccine Covaxin by the World Health Organization (WHO) has meant many an anxious moment for several individuals who have received it and are unable to travel to certain countries because of lack of approval to Covaxin.
A petition in the Supreme Court had sought permission for such individuals to get Covishield voluntarily. However, the Apex Court has said it will wait for the WHO’s decision before allowing such individuals to get the AstraZeneca vaccine jabs.
The petition by SC lawyer Kartik Sheth had highlighted the anxiety of fully vaccinated individuals wanting to travel abroad but unable to do so because of lack of WHO approval to Covaxin. It submitted that they be allowed to get Covishield at their own cost and risk
To this, the SC bench of Justices DY Chandrachud and BV Nagarathna observed that Bharat Biotech had made a representation to the WHO. “Let’s wait for WHO authorisation and hear it after Diwali,” the bench said.
While Covishield has got WHO approval, Covaxin is yet to get it. Thus, countries like US, UK, Germany, Canada, etc continue to treat Covaxin-vaccinated persons as unvaccinated.
To read the latest news in Gujarati click here